Beyond Medical Financials

DOCKF Stock  USD 0.02  0  22.70%   
Based on the analysis of Beyond Medical's profitability, liquidity, and operating efficiency, Beyond Medical Technologies may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Beyond Medical's Net Tangible Assets are most likely to increase significantly in the upcoming years. The Beyond Medical's current Accounts Payable is estimated to increase to about 139.6 K, while Total Current Liabilities is projected to decrease to roughly 332.3 K. Key indicators impacting Beyond Medical's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio0.210.2222
Notably Down
Very volatile
Investors should never underestimate Beyond Medical's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Beyond Medical's cash flow, debt, and profitability to make informed and accurate decisions about investing in Beyond Medical Technologies.

Net Income

(625,762)

  
Understanding current and past Beyond Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Beyond Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Beyond Medical's assets may result in an increase in income on the income statement.

Beyond Medical Stock Summary

Beyond Medical competes with Vera Bradley, CenterPoint Energy, GE Vernova, Alliant Energy, and Antero Midstream. Beyond Medical Technologies Inc. engages in the manufacturing and distribution of personal protective equipment in Canada. The company was incorporated in 2006 and is headquartered in Vancouver, Canada. Beyond Med is traded on OTC Exchange in the United States.
Specialization
Industrials, Pollution & Treatment Controls
InstrumentUSA Stock View All
ExchangeOTCCE Exchange
Business Address1055 West Georgia
SectorMachinery
IndustryIndustrials
BenchmarkDow Jones Industrial
Websitewww.beyond-md.ca
Phone604 805 4602
CurrencyUSD - US Dollar

Beyond Medical Key Financial Ratios

Beyond Medical Key Balance Sheet Accounts

201920202021202220232024 (projected)
Net Tangible Assets8.2M3.5M1.5M1.5M1.4M2.7M
Retained Earnings(16.7M)(22.3M)(25.3M)(25.6M)(26.1M)(27.4M)
Accounts Payable59.1K186.8K174.6K86.8K104.1K139.6K
Net Receivables62.4K166.2K115.7K38.6K2.9K0.0
Total Current Assets3.4M1.2M1.8M579.3K95.6K90.9K
Common Stock18.0M18.5M20.8M23.6M27.1M17.0M
Total Assets3.8M1.8M2.0M608.2K95.6K90.9K
Cash2.8M624.2K1.4M536.8K64.1K60.9K
Other Assets489.9K7.5K36.9K30.5K27.4K26.1K
Other Current Assets5.0K2.8K30.1K1.3K1.2K1.1K
Total Liab305.7K361.9K413.3K346.9K430.4K355.3K
Net Invested Capital3.5M1.5M1.5M261.2K(304.7K)(289.5K)
Net Working Capital3.3M920.4K1.4M232.4K(334.7K)(318.0K)

Beyond Medical Key Income Statement Accounts

201920202021202220232024 (projected)
Net Interest Income54.2K7.0K(14.2K)(10.5K)(9.4K)(8.9K)
Operating Income(2.8M)(2.1M)(2.1M)(836.9K)(548.5K)(575.9K)
Ebit(3.2M)(2.0M)(2.1M)(836.9K)(962.5K)(1.0M)
Ebitda(2.9M)(2.7M)(1.9M)(2.7M)(2.5M)(2.6M)
Income Before Tax(5.4M)(6.5M)(2.9M)(835.1K)(552.0K)(579.6K)
Net Income(5.4M)(6.5M)(2.9M)(1.4M)(596.0K)(625.8K)
Research Development126.2K28.6K20.9K110.2K99.2K85.7K

Beyond Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Beyond Medical's current stock value. Our valuation model uses many indicators to compare Beyond Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Beyond Medical competition to find correlations between indicators driving Beyond Medical's intrinsic value. More Info.
Beyond Medical Technologies is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . At this time, Beyond Medical's Return On Equity is most likely to increase slightly in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Beyond Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Beyond Medical Techn Systematic Risk

Beyond Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Beyond Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Beyond Medical Techn correlated with the market. If Beta is less than 0 Beyond Medical generally moves in the opposite direction as compared to the market. If Beyond Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Beyond Medical Techn is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Beyond Medical is generally in the same direction as the market. If Beta > 1 Beyond Medical moves generally in the same direction as, but more than the movement of the benchmark.

About Beyond Medical Financials

What exactly are Beyond Medical Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Beyond Medical's income statement, its balance sheet, and the statement of cash flows. Potential Beyond Medical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Beyond Medical investors may use each financial statement separately, they are all related. The changes in Beyond Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Beyond Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
Today, most investors in Beyond Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Beyond Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Beyond Medical growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0111

At this time, Beyond Medical's Price Earnings To Growth Ratio is most likely to slightly decrease in the upcoming years.

Beyond Medical November 28, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Beyond Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Beyond Medical Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Beyond Medical Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Beyond Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Beyond Medical's daily price indicators and compare them against related drivers.

Complementary Tools for Beyond Stock analysis

When running Beyond Medical's price analysis, check to measure Beyond Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beyond Medical is operating at the current time. Most of Beyond Medical's value examination focuses on studying past and present price action to predict the probability of Beyond Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beyond Medical's price. Additionally, you may evaluate how the addition of Beyond Medical to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Fundamental Analysis
View fundamental data based on most recent published financial statements